FAT LOSS
Tirzepatide — dual GLP-1/GIP agonist
Also known as: Mounjaro, Zepbound, Tirz
Tirzepatide (Mounjaro, Zepbound) is the first dual GLP-1/GIP receptor agonist. SURMOUNT trials showed average 22.5% weight loss at 72 weeks with the 15 mg dose.
99%+ purity · Janoshik HPLC verified
Prices
Tirzepatide · 10mg
1 vial35€
5-pack140€
Mechanism
Simultaneous GLP-1 and GIP agonism — appetite suppression plus improved insulin sensitivity.
Trials
SURMOUNT-1: -22.5% body weight. SURPASS-2 head-to-head vs semaglutide showed superior weight and HbA1c outcomes.
Frequently asked questions
Where to buy?
gFITpeps.lt ships research-grade tirzepatide across the EU.
Research use only. Not for human consumption.